Literature DB >> 23736275

Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale.

Kivanc Akad1, Dilek Solmaz, Ismail Sari, Fatos Onen, Nurullah Akkoc, Servet Akar.   

Abstract

The aim of this study was to compare the performance characteristics of two answer modalities for BASDAI and BASFI in patients with AS and to show validity and reliability of NRS in Turkish version. BASDAI and BASFI were simultaneously employed with a 10-cm VAS and an 11-point NRS. Internal consistency was assessed by using Cronbach's alpha coefficients. Testing was performed on baseline and next day under standardized conditions. Construct validity was determined by association of these measures with ASDAS, DFI, global disease activity, pain scores, ASQOL, HAQ, and SF-36. We also tested the ability of NRS version of BASDAI and BASFI to detect changes. A total 114 patients with AS according to the modified New York criteria were included. There was a good agreement between the total scores of each instrument on day 0 (ICC values were 0.894-0.934). Scores of the both answering modality of each instrument were correlated with ASDAS-CRP, and the scores of DFI, patient global assessment of disease activity and patient-reported pain, ASQOL, HAQ. Response time for BASDAI and BASFI was significantly shorter in NRS answer modality (P < 0.001). Our patients found NRS modality more comprehensible and easier to understand (P < 0.001). Our results showed the validity of NRS version of BASDAI and BASFI and provided an evidence for using these questionnaires in 11-point NRS answer modality in Turkish AS patients.

Entities:  

Mesh:

Year:  2013        PMID: 23736275     DOI: 10.1007/s00296-013-2789-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Sample size calculation for an agreement study.

Authors:  Jason J Z Liao
Journal:  Pharm Stat       Date:  2010 Apr-Jun       Impact factor: 1.894

Review 2.  Assessment and treatment of ankylosing spondylitis: current status and future directions.

Authors:  Jane Zochling
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

Review 3.  The measurement of pain.

Authors:  H A Bird; J S Dixon
Journal:  Baillieres Clin Rheumatol       Date:  1987-04

4.  The measurement of clinical pain intensity: a comparison of six methods.

Authors:  Mark P Jensen; Paul Karoly; Sanford Braver
Journal:  Pain       Date:  1986-10       Impact factor: 6.961

Review 5.  Pain measurement in the elderly: a review.

Authors:  C S Rodriguez
Journal:  Pain Manag Nurs       Date:  2001-06       Impact factor: 1.929

6.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  Measurement of pain: patient preference does not confound pain measurement.

Authors:  E Kremer; J H Atkinson; R J Ignelzi
Journal:  Pain       Date:  1981-04       Impact factor: 6.961

9.  Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.

Authors:  Astrid Van Tubergen; Iris Debats; Liliane Ryser; John Londoño; Ruben Burgos-Vargas; Mario H Cardiel; Robert Landewé; Gerold Stucki; Désirée Van Der Heijde
Journal:  Arthritis Rheum       Date:  2002-06-15

Review 10.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

View more
  6 in total

1.  Validity and reliability of the Short Form 36 Health Surveys (SF-36) among patients with spondyloarthritis in Singapore.

Authors:  Yu Heng Kwan; Warren Weng Seng Fong; Nai Lee Lui; Si Ting Yong; Yin Bun Cheung; Rahul Malhotra; Truls Østbye; Julian Thumboo
Journal:  Rheumatol Int       Date:  2016-09-23       Impact factor: 2.631

Review 2.  The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis.

Authors:  Xiao Yang; Dazhi Fan; Qing Xia; Mengmeng Wang; Xu Zhang; Xiaona Li; Guoqi Cai; Li Wang; Lihong Xin; Shengqian Xu; Faming Pan
Journal:  Qual Life Res       Date:  2016-06-20       Impact factor: 4.147

3.  Searching for optimal rating scales in the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).

Authors:  Franco Franchignoni; Fausto Salaffi; Alessandro Ciapetti; Andrea Giordano
Journal:  Rheumatol Int       Date:  2013-11-09       Impact factor: 2.631

4.  Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis.

Authors:  Sadık Volkan Emren; Onay Gerçik; Emre Özdemir; Dilek Solmaz; Nihan Eren; Ersin Çağrı Şimşek; Mehmet Tokaç; Zeynep Emren; Gökhan Kabadayı; Servet Akar
Journal:  Eur J Rheumatol       Date:  2019-11-25

5.  Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).

Authors:  Dilek Solmaz; Tulay Yildirim; Okan Avci; Nazmiye Tomas; Servet Akar
Journal:  Clin Rheumatol       Date:  2015-12-16       Impact factor: 2.980

6.  miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes.

Authors:  Dina Salem Fotoh; Rasha Ibrahim Noreldin; Mohamed Soliman Rizk; Maha Mohamed Elsabaawy; Heba Ahmed Esaily
Journal:  J Immunol Res       Date:  2020-12-28       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.